The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shah Jatin since 2020.
This trader's CIK number is 1782186.
At the time of last reporting, Shah Jatin was the EVP, Chief Medical Officer of Karyopharm Therapeutics Inc.. (stock ticker symbol KPTI).
Also see all insider trading activities at Karyopharm Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | KPTI | 0 | $0 | 3,010 | $32,636 | 0 | $0 |
| 2021 | KPTI | 23,250 | $199,996 | 2,934 | $44,716 | 10,500 | $0 |
| 2020 | KPTI | 0 | $0 | 1,964 | $34,123 | 7,263 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-02-17 | KPTI | Sale | 1,306 | 12.12 | 15,832 |
| 2022-02-07 | KPTI | Sale | 1,704 | 9.86 | 16,804 |
| 2021-05-07 | KPTI | Buy | 23,250 | 8.60 | 199,996 |
| 2021-02-18 | KPTI | Sale | 1,186 | 14.83 | 17,589 |
| 2021-02-11 | KPTI | Sale | 1,748 | 15.52 | 27,127 |
| 2021-02-15 | KPTI | Option Ex | 4,850 | .00 | 0 |
| 2021-02-05 | KPTI | Option Ex | 5,650 | .00 | 0 |
| 2020-07-11 | KPTI | Option Ex | 2,413 | .00 | 0 |
| 2020-07-15 | KPTI | Sale | 589 | 19.46 | 11,461 |
| 2020-02-19 | KPTI | Sale | 1,375 | 16.48 | 22,662 |
| 2020-02-15 | KPTI | Option Ex | 4,850 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shah Jatin (EVP, Chief Medical Officer of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.